W. Hildebrand

A newly established canine NK-type cell line and its cytotoxic properties.

A. Rapak, B. Obmińska-Mrukowicz, E. Wysokińska, 2021, Veterinary and comparative oncology.

Ubiquitin‐specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies

V. Smits, R. Freire, A. Rapak, 2021, Journal of veterinary internal medicine.

An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma

A. Rapak, A. Miazek, Marta Lisowska, 2019, Cancers.

Development of novel monoclonal antibodies to dog leukocyte antigen DR displaying direct and immune‐mediated cytotoxicity toward canine lymphoma cell lines

A. Rapak, A. Miazek, Marta Lisowska, 2018, Hematological oncology.

A novel canine B‐cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics

S. Dzimira, P. Dzięgiel, A. Rapak, 2017, Veterinary and comparative oncology.

Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype

E. Shpall, M. Fernandez-Vina, L. Hurton, 2010, Leukemia.

Studies on Johne's Disease in Cattle in Northern Ireland: I. Incidence and Development

W. Hildebrand, J. Pearson, T. McClelland, 1962 .

Mast cell tumor.

J. Nicpoń, M. Nowak, W. Hildebrand, 2013 .